Normal blood-derived monocyte/macrophages were found to be susceptible to infection in vitro by human T lymphotropic virus type III (HTLV-III), the etiologic agent of the acquired immunodeficiency syndrome. In addition, HTLV-III was recovered from monocyte/macrophages of patients infected with this virus. The above findings raise the possibility that HTLV-III-infected monocyte/macrophages may serve as a vehicle for the dissemination of virus to target organs and as a reservoir for viral persistence, as has been shown for other lentiviruses including visna virus and caprine arthritis encephalitis virus.
Introduction
Human T lymphotropic virus type III (HTLV-III)' (1) , also known as lymphadenopathy-associated virus (2) , is the etiologic agent of the acquired immunodeficiency syndrome (AIDS). This retrovirus is tropic and cytopathic for helper-inducer (T4) lymphocytes (3), resulting in profound defects in cell-mediated immunity (4) . In addition, HTLV-III is neurotropic and capable of directly causing a number of neurologic syndromes (5, 6) . Several recent preliminary reports suggest that HTLV-III may also infect monocytes or macrophages. Two groups have noted that the human monocytic cell line, U-937, was susceptible to HTLV-III infection in vitro (7, 8) . Retroviral particles resembling HTLV-III have also been detected by electron microscopy in macrophages in lymph node (9) and brain (10) of HTLV-III infected individuals.
Whether monocyte/macrophages are susceptible to HTLV-III infection has important implications. Recent studies suggest that HTLV-III is closely related to a group of nononcogenic, cytopathic retroviruses (lentiviruses), including visna virus, caprine arthritis encephalitis virus, and possibly equine infectious anemia virus (1 1-13). For these lentiviruses, the major target of infection is the monocyte/macrophage, which serves as a vehicle for the dissemination of virus to other sites and as a reservoir for viral persistence (14, 15) . We, therefore, studied the susceptibility of normal human monocyte/macrophages to HTLV-III (10 mM) , L-glutamine (2 mM), penicillin (250 U/ml), streptomycin (250 ,g/ml), and fetal calf serum (20%). In addition, four 8-well plastic slide-culture chambers (LAB-TEK, Naperville, IL) were also inoculated with normal peripheral blood mononuclear cells at 1 X 106 cells/cm2. The cells were not activated with mitogens or interleukin 2. On days I and 2, nonadherent cells and supernatant fluids were removed from the flasks and slide-culture chambers. The plasticadherent cells were then washed three times with phosphate-buffered saline before being replenished with fresh medium. On day 3, the remaining plastic-adherent cells were subjected to two episodes of complement-mediated T cell lysis using OKT3 monoclonal antibody (Ortho Diagnostic Systems, Inc., Raritan, NJ) and rabbit complement (see below). On day 4, one of the two 25-cm2 flasks and two of the four slideculture chambers were then inoculated with cell-free HTLV-IIIB at a dose of 8 X 102 50% tissue culture infective doses (TCID50)/cm2. The other corresponding flask and slide-culture chambers were used as controls and were mock-infected with virus-free H9 culture supernatant fluid. Subsequently, complete medium changes were performed every 3-4 d. Between days 12 and 17, the 25-cm2 cultures were assayed for reverse transcriptase (RT) activity and infectious virus, while the slide-chamber cultures were examined for expression ofHTLV-III antigens and OKT3, OKB7, OKM5, and OKM I (all obtained from Ortho Diagnostic Systems) markers by a fixed-cell indirect immunofluorescence technique. A total of four such experiments were conducted.
Isolation ofHTL V-Ill from monocyte/macrophages ofinfected persons. Peripheral blood mononuclear cells (50 X 106) from four patients were separately seeded into 25-cm2 flasks in 5 ml RPMI 1640 medium with supplements described above but without mitogens or interleukin 2. Additional cells were also seeded into 8-well slide-culture chambers at a density of 2 X 106/cm2. On day 1, nonadherent cells were removed, and the attached cells were washed extensively with phosphate-buffered saline. Washings were repeated on day 2, followed by two courses of complement-mediated T cell lysis (see below). On day 3, after three more washings, 5 X 106 normal peripheral blood mononuclear cells from HTLV-III seronegative subjects, preactivated with phytohemagglutinin (10 jg/ml; Sigma Chemical Co.) and pretreated with Polybrene (2 ,ig/ ml; Sigma Chemical Co.), were cocultivated with patients' plastic-adherent, T cell-depleted monocyte/macrophages in the 25-cm2 flasks. The cells in the slide-culture chambers were fixed in acetone and examined for phenotypic expression ofOKT3, OKB7, OKM5, and OKM I markers. Subsequently, the cocultures, maintained in medium containing 10% interleukin 2 (Electro-Nucleonics, Inc., Fairfield, MD), were serially monitored for RT activity and HTLV-III-specific antigen expression. As controls, 2 X 106 ofthe nonadherent mononuclear cells removed on day 1 were also subjected twice to complement-mediated T cell lysis. The remaining cells and debris, after extensive washings, were also cocultured with preactivated normal peripheral blood mononuclear cells (5 X 106).
In parallel, these cultures were also assayed sequentially for RT activity.
Reverse transcriptase assay. Viruses in cell-free supernatant fluids (3 ml) were precipitated with polyethylene glycol (1.5 ml), and the particulate reverse transcriptase activity was assayed as previously described (18, 19) .
Indirect immunofluorescence assay. HTLV-III antigen expression was assessed using a human immune serum, which is strongly positive for HTLV-III antibodies as tested by enzyme-linked immunosorbent assay and immunoblot technique. Expression of pan-T cell marker, B cell marker, and monocyte markers were determined by using OKT3, OKB7, OKM5, and OKM 1 monoclonal antibodies. The fixed-cell indirect immunofluorescence tests were performed as previously described (18, 20 (Fig. 1) . These three viral isolates were confirmed as HTLV-III by specific immunofluorescence on days 15 and 19 of culture. To control for the possibility that the above findings were due to minor T cell contamination, we also cultured the nonadherent, T cell-rich mononuclear cells removed on day 1 and subjected to two consecutive treatments of complementmediated T cell lysis. All four of these cultures were RT-negative.
These results indicate that the three isolates derived from the plastic-adherent cells were indeed harbored within the monocyte/ macrophage population in the patients.
Discussion
We have shown that normal, blood-derived monocyte/macrophages can be infected by HTLV-III in vitro. The level of virus replication, however, appears to be low compared with the levels detected in H9 cells or normal peripheral blood lymphocytes. It is unlikely that contamination by residual T lymphocytes accounted for our finding because of the following reasons: extensive washings of the plastic-adherent cells, -2 wk of in vitro culture without mitogens or interleukin 2, two consecutive courses ofcomplement-mediated lysis using OKT3 monoclonal antibody, and the lack of any immunofluorescent staining using OKT3 monoclonal antibody. The plastic-adherent cells were shown to be monocyte/macrophages by their strong, 80-90% immunofluorescence with both OKM 1 and OKM5 monoclonal antibodies. OKM1 monoclonal antibody also binds to granulocytes and null cells, and OKM5 monoclonal antibody also reacts with platelets. However, only monocyte/macrophages are (24) have anecdotally reported the isolation of AIDS virus from macrophages of patients with AIDS. Here, we have also shown the isolation of HTLV-III from OKM 1 + and OKM5+ plastic-adherent cells derived from blood ofthree patients who are known to be infected by the virus. This finding is unlikely to be the result of T cell contamination, because the immunofluorescent staining of cultured cells with OKT3 monoclonal antibody was negative, and we were unable to isolate HTLV-III from nonadherent, T cell-rich peripheral blood mononuqear cells following two courses of complementmediated lysis using OKT3 monoclonal antibody. Therefore, we conclude that monocyte/macrophages from infected individuals can harbor HTLV-III in vivo.
The infection of monocyte/macrophages by HTLV-III in vitro and in vivo has important implications. Monocyte/macrophages may serve as an important reservoir for the persistence of HTLV-III in infected individuals. For the related lentiviruses, visna and caprine arthritis encephalitis viruses, latently infected monocytes and their precursors in the bone marrow are believed to be the major reservoir of infectious virus and the principal site for viral persistence (14, 25) . In addition, HTLV-III infected monocyte/macrophages may function as a vehicle in the dissemination of the virus to target organs. This may also be similar to visna virus and caprine arthritis encephalitis virus infections, where latently-infected monocytes can deliver the viruses to lungs, central nervous system, and joints. Subsequently, with the differentiation of monocytes to macrophages, active viral replication occurs, resulting in inflammation and disease at those sites (12, 14) . Perhaps, HTLV-III enters the central nervous system in a similar fashion, with the monocyte serving as the "Trojan horse". The terminal differentiation of the monocyte may then trigger HTLV-Ill replication and release, which in turn can lead to inflammation and destructive changes in the brain. 
